Results

Total Results: 1,767 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
    January 01, 2017 - events ��� Subgroup of 1 RCT 2269 Age and race do not affect the efficacy of either drug ��� Prophylactic … �� Gastrointestinal symptoms, fatigue, and headache �� Rare adverse effects include leukopenia, aplastic … effects include bone marrow suppression, aseptic meningitis, and dermatological adverse events �� Serious … adverse effects include gastrointestinal perforations, ulcers, and increased risk of heart attack or … effects include cardiovascular thromboembolic events, hepatic failure, TEN, SJS, and DRESS NSAIDs =
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse eventsadverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverseevents: 4.65% (10/215) vs.
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse eventsadverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverseevents: 4.65% (10/215) vs.
  4. effectivehealthcare-admin.ahrq.gov/products/vaccine-safety/research-protocol
    December 01, 2020 - events, typically enrolling several hundred subjects. … What adverse events (AEs) are collected in clinical studies (phases I–IV) and in observational studies … Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety … event CTCAE = Common Terminology Criteria for Adverse Events Hib = Haemophilus influenzae type b … Adverse events of interest, included in electronic search terms Adverse event Vaccine type
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-270-bimp-executive-summary.pdf
    May 01, 2024 - • Evidence regarding adverse effects among individuals of any age, effectiveness for children and … potentially beneficial alternative or adjunct to pharmacoprevention, which may be associated with adverseAdverse events were often not ascertained systematically, and the extent to which behavioral interventions … are associated with any adverse events remains understudied (though rarely reported), as was delivery … Adverse events are rarely reported, although this appears understudied.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/inguinal-hernia_research-protocol.pdf
    August 15, 2011 - no mesh Outcomes Patient-oriented effectiveness outcomes and adverse events (see list of outcomes … Adverse events include any unintended effects such as chronic pain, infection, small bowel perforation … The following will always be considered objective outcomes: adverse events, hospital stay, office … This item will only be used for the following outcomes: hernia recurrence, adverse events, QOL, FCT … MCSDs for different adverse events If meta-analysis is deemed appropriate and possible for a given
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - adverse events according to drug class? … Harms and Adverse Events a. … adverse events according to drug class? … events, and serious adverse events. … Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events,
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
    December 29, 2015 - When lesinurad was combined with xanthine oxidase inhibitors, commonly reported adverse events were … However, the experts warned that lesinurad uptake could be limited by concern about adverse events, … adverse events, than patients given placebo. … Occurrence of adverse events, including serious events, was similar in patients given baricitinib or … Adverse events/nonfatal serious adverse events rates were 78.1%/8.6% and 82.4%/12.9% in patients who
  9. effectivehealthcare-admin.ahrq.gov/products/medicine-safety-call-center/research
    November 01, 2017 - Abstract Adverse drug events impose a large cost on the society in terms of lives and healthcare costs … In this paper, we propose an information technology architecture for enabling the monitoring of adverse … drug events in an outpatient setting as a part of the post marketing surveillance program. … on previous studies analyzing the involvement of community pharmacies in identifying and reporting adverse … drug events.
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - When lesinurad was combined with xanthine oxidase inhibitors, commonly reported adverse events were … However, they warned, lesinurad uptake could be limited by adverse events, such as kidney complications … back pain, nasopharyngitis, and upper respiratory tract infection.6 The most common adverse events … The experts warned that lesinurad uptake could be limited by adverse events such as kidney complications … events, which could require additional adverse event monitoring while patients are taking lesinurad
  11. effectivehealthcare-admin.ahrq.gov/products/restless-legs/research
    December 01, 2019 - assessed RLS symptom impact, sleep scale scores, disease-specific quality of life, withdrawals, and adverse … Dopamine agonists resulted in more patients who experienced at least one adverse event (high-strength … Treatment withdrawals were due to lack of efficacy (6% to 37%) as well as augmentation and other adverseevents. … Adverse effects of pharmacologic therapies and long-term treatment withdrawals due to adverse effects
  12. effectivehealthcare-admin.ahrq.gov/products/head-neck-cancer-update/clinician
    December 01, 2019 - This is a summary of a systematic review update evaluating recent evidence on the effectiveness and adverse … The present review assessed the comparative effectiveness and adverse effects of 3DCRT, IMRT, SBRT, and … Clinical Bottom Line Summary of Key Findings and Strength of Evidence for the Benefits and Adverseevents (e.g., dysphagia) and improving quality of life In understanding how outcomes are affected … events information Assessing quality of life and other patient-reported outcomes with validated instruments
  13. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
    September 01, 2009 - Number 17 Effective Health Care 2 cancer by the Gail model or other criteria and low risk for adverseevents. … Use of medications to reduce risk of breast cancer Adverse effects of medications 1, 3, 4 Women … events and ≤4 percent for nonprotocol-specified events … Further research to more clearly identify characteristics of individuals experiencing specific adverse
  14. effectivehealthcare-admin.ahrq.gov/products/cancer-anemia-update/research-protocol
    December 01, 2019 - Adverse events related to transfusions reported in included studies will be incorporated in the review … As noted in the previous report, transfusion-related adverse events are uncommon. … Adverse effects limited to thromboembolic events, hypertension, rash and similar symptoms, seizures, … rEPO antibodies, and transfusion adverse events.   … effect*” OR “adverse drug reaction*” OR “side effect*” OR “toxic effect*” OR “adverse event*” OR “complication
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - to adverse events)? … events, withdrawal due to adverse events, renal dysfunction, hepatotoxicity, QT interval, and bleeding … No withdrawals due to adverse events or other adverse events were observed.59 Garlic Four small short-term … events, bleeding, renal dysfunction, hepatotoxicity, and serious adverse events). … events,42,73 renal dysfunction,42,73 serious adverse events,42 diarrhea,73 vomiting,73 nausea,73 adverse
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
    September 01, 2016 - events by organ system. 2. … • Adverse event and deaths. … ClinicalTrials.gov began to mandate reporting of adverse events in September 2009 as serious adverseevents and non-serious adverse events. … We will compare the total adverse events reported in ClinicalTrials.gov compared with the total reported
  17. effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management-1/research
    May 01, 2019 - drug events) and real (adverse drug events being a subset of the drug related problems) drug related … Adverse Drug Events The assessment of a medication therapy management program designed to impact adverse … We chose a validated research tool to assess adverse drug events. … The costs associated with adverse drug events among older adults in the ambulatory setting. … Risk factors for adverse drug events among older adults in the ambulatory setting.
  18. effectivehealthcare-admin.ahrq.gov/products/mhs4-opioid-stewardship/rapid-research
    December 01, 2023 - interventions promote the appropriate use of prescribed and ordered opioids to reduce the risk of opioid adverseevents. … Drug Events Related to Anticoagulant Use in Adults Rapid Evidence Product | Feb 1, 2024 … Product | Feb 9, 2024 Computerized Clinical Decision Support To Prevent Medication Errors and Adverse … Drug Events View Collection Related Product Making Healthcare Safer IV collection
  19. effectivehealthcare-admin.ahrq.gov/products/cancer-venous-thrombosis-anticoagulation/abstract
    December 01, 2019 - Home Evidence Reports Anticoagulation for Venous Thromboembolic Events … Objective: To evaluate the outcomes of recurrent thrombosis, bleeding events, and survival for advanced … Project Timeline Anticoagulation for Venous Thromboembolic Events in Patients with Cancer Dec 15 … 2024 Alternative Payment Models Rapid Evidence Product Jan 16, 2024 Reducing Adverse … Drug Events Related to Anticoagulant Use in Adults Systematic Review Oct 12, 2020
  20. effectivehealthcare-admin.ahrq.gov/products/weight-loss-surgery/research-protocol
    December 01, 2019 - Secondary outcomes: Health care utilization/economics Quality-of-life measures Adverse eventsevents: bowel obstruction, incisional hernia RYGB-specific adverse events: anastomosis complications … (i.e., staple-line disruption or ulcer), nutritional deficiencies LAGB-specific adverse events: band-related … events: Short-term: mortality systemic medical complications (i.e. myocardial infarction … The evidence of risks (adverse events) will be summarized for each surgical procedure and nonsurgical

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: